Last edition
News about Manufacturing
Lupin's Aurangabad Facility Receives EIR from U.S. FDA
Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) from the U.S. FDA for its Aurangabad, India facility. The inspection for the facility was carried out by the U.S. FDA between February 10, 2020 and February 14, 2020 and concluded with no observations
Manufacturing | 03/04/2020 | By Darshana | 1169
COVID-19 Testing Kits: Mylab Signs Deal With Serum
Mylab Discovery Solutions, the first Indian company whose testing kit was approved by the Indian Council of Medical Research (ICMR), has tied up with Serum Institute of India, world's largest vaccine manufacturer by number of doses produced, to scale up the operations and escalate faster delivery of testing kits
Manufacturing | 02/04/2020 | By Darshana | 549
Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)
Pharma major Lupin Limited (Lupin) announced the launch of Betamethasone Dipropionate Ointment USP (Augmented), 0.05%, having received an approval from the United States Food and Drug Administration (U.S. FDA) earlier. The product would be manufactured at Lupin’s Pithampur (Unit III) facility, India
Manufacturing | 21/03/2020 | By Darshana | 955
BELLUS Health Inc, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that it has completed patient enrollment for the RELIEF trial, its dose-escalation, placebo-controlled Phase 2 trial of BLU-5937 in patients
Manufacturing | 21/03/2020 | By Darshana | 579
Medivir and Tango Therapeutics sign license agreement for preclinical asset
Medivir today announced that it has entered into a license agreement with US biotech company Tango Therapeutics for one of Medivir’s preclinical research programs
Manufacturing | 17/03/2020 | By Darshana | 259
Lupin launches Ethacrynic Acid Tablets USP
Pharma major Lupin Limited (Lupin) announced the launch of Ethacrynic Acid Tablets USP, 25 mg, having received approval from the United States Food and Drug Administration (U.S. FDA) earlier. The product would be manufactured at Lupin's Nagpur OSD facility, India
Manufacturing | 14/03/2020 | By Darshana | 800
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy